Ameriprise
CFMS

Ameriprise’s Conformis, Inc. Common Stock CFMS Stock Holding History

Ameriprise’s Portfolio CFMS Stock Details CFMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-400
Closed -$29K – 3810
2019
Q1 		$29K Sell
400
-2,323
-85% -$66.2K ﹤0.01% 3664
2018
Q4 		$25K Hold
2,723
– – ﹤0.01% 3589
2018
Q3 		$73K Buy
2,723
+400
+17% +$10.9K ﹤0.01% 3643
2018
Q2 		$73K Sell
2,323
-41
-2% -$1.42K ﹤0.01% 3586
2018
Q1 		$85K Buy
2,364
+400
+20% +$16.8K ﹤0.01% 3564
2017
Q4 		$117K Buy
+1,964
New +$157K ﹤0.01% 3548
2016
Q2 		– Sell
-2,457
Closed -$660K – 3862
2016
Q1 		$660K Sell
2,457
-583
-19% -$154K ﹤0.01% 3044
2015
Q4 		$1.31M Sell
3,040
-9,044
-75% -$4.54M ﹤0.01% 2825
2015
Q3 		$5.46M Buy
+12,084
New +$6.09M ﹤0.01% 1952

Other funds holding CFMS

ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QI
QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise's CFMS Position: Q2 2019 in Review

Ameriprise sold out of Conformis, Inc. Common Stock (CFMS) in Q2 2019, closing a stake of 400 shares — an estimated $29K sold.

Ameriprise first reported a position in CFMS in Q3 2015 and held it in 9 quarters. The position peaked at $5.46M in Q3 2015. 91 funds tracked by Wall St. Rank hold CFMS as of Q2 2019.

  • Ameriprise reported no remaining Conformis, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Ameriprise sold 400 Conformis, Inc. Common Stock shares in Q2 2019, an estimated $29K.
  • Ameriprise first reported a position in Conformis, Inc. Common Stock in Q3 2015 and held it in 9 quarters.
  • Ameriprise's Conformis, Inc. Common Stock position peaked at $5.46M in Q3 2015.
  • 91 funds tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q2 2019.

Based on Ameriprise's 13F filing for Q2 2019, filed 14 Aug 2019.